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Central venous catheters (CVC) are vital in present-day medical practice, particularly in  
the intensive care unit (ICU). However, their use puts patients at risk for developing central line- 
associated bloodstream infections (CLABSIs).  Forty-eight percent of ICU patients have central 
lines, accounting for about 15 million central-line-catheter-days per year (Institute for Healthcare 
Improvement [IHI], 2012). Central line-associated blood stream infections are one of the 
deadliest types of hospital acquired infections (HAIs) with a mortality rate near 18%, and are the 
sources of considerable morbidity and health care costs (CDC, 2011; Burke, 2003; Glance, 
Stone, Mukamel, & Dick, 2011). CLABSIs require additional treatments that impose substantial 
economic consequences. The downstream effects of these infections include extended illness, 
loss of wages, and the intangible costs related to a reduced quality of life. These bloodstream 
infections prolong hospitalization by a mean of seven days, and the estimated attributable cost 
per infection is between $3,700 and $39,000 (Institute for Healthcare Improvement, 2012).The 
overall direct medical costs of HAIs, (including CLABSI) in hospitals in the United States range 
from 28.4 to 33.8 billion dollars annually (Klevens et al., 2007). 
The Association for Professionals in Infection Control and Epidemiology (APIC)  
 
promotes a culture of zero tolerance for HAIs (APIC, 2012). The Institute for Healthcare  
 
Improvement (IHI) has described care bundles, or groups of best practices with respect to a 
disease process, that when used together result in superior patient outcomes.  Research 
demonstrates that ICUs which have implemented multiple preventive interventions, including 
central line bundles, have nearly eliminated CLABIs (Behrenholtz et al., 2004).  However, 
sustained reduction of CLABSIs remains intangible in many institutions despite increased 
awareness of evidence-based preventive strategies, publication of successful hospital CLABSI 
elimination programs, and elimination of reimbursement for the cost of treating CLABSIs 
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(Agency for Healthcare Research and Quality, 2010; IHI, 2012; The Society of Healthcare 
Epidemiology of America; 2014).   
The key to achieving sustainable CLABSI reduction is to combine adaptive cultural 
changes with evidence-based practices. The Joint Commission requires hospitals to conduct 
periodic risk assessments, measure CLABSI rates, monitor compliance with best practices, 
evaluate effectiveness of prevention efforts, provide rate data and outcome measures to key 
stakeholders, evaluate all CVCs routinely, and remove nonessential catheters (The Joint 
Commission, 2014). This practice inquiry project is an evaluation of provider adherence to an 
evidence-based CLABSI prevention guideline utilizing daily chlorhexidine gluconate patient 
bathing. The evaluation of provider guideline adherence will provide insight and guide future 
quality improvement initiatives in the prevention of CLABSIs. This practice inquiry project 
includes three manuscripts, each of which discusses relevant aspects of CLABSIs prevention 
utilizing daily whole body chlorhexidine gluconate bathing.   
• Manuscript one is an evidence review of the literature to (i) determine the potential 
impact of iatrogenic blood loss on the development of anemia, and (ii) to evaluate the 
effectiveness of available blood conservation devices and strategies in decreasing 
iatrogenic anemia and blood transfusions in adult ICU patients. 
• Manuscript two is a cost-analysis of the potential financial benefits of implementing daily  
whole body patient bathing with 2% Chlorhexidine Gluconate impregnated cloths in a large  
university level-1 trauma center . 
• Manuscript three describes the development, implementation, and evaluation of a 
blood conservation education intervention, and its impact on nursing knowledge and 
attitudes towards future implementation of blood conservation practices. 
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Abstract 
 
 
The complexity of the healthcare system is increasing, and the moral duty to provide 
quality patient care is threatened by the sky rocketing cost of healthcare. A major concern for 
both patients and the hospital’s economic bottom line are hospital-acquired infections (HAIs), 
including central line associated blood stream infections (CLABSIs). These often serious 
infections result in significantly increased patient morbidity, mortality, length of stay, and use of 
health care resources. Historically, most infection prevention and control measures have focused 
on aseptic technique of health care providers and in managing the environment. Emerging 
evidence for the role of host decontamination in preventing HAIs is shifting the paradigm and 
paving a new path for novel infection prevention interventions. Chlorhexidine gluconate has a 
long-standing track record of being a safe and effective product with broad antiseptic activity, 
and little evidence of emerging resistance. As the attention is directed toward control and 
prevention of HAIs, chlorhexidine-containing products may prove to be a vital tool in infection 
control. Increasing rates of multidrug-resistant organisms (MDROs), including methicillin-
resistant Staphylococcus aureus (MRSA), Acinetobacter baumanniic and vancomycin-resistant 
Enterococcus (VRE) demand that evidence-based research drive all interventions to prevent 
transmission of these organisms and the development of HAIs.  This review of literature 
examines current evidence related to daily chlorhexidine gluconate bathing and its impact on 
CLABSI rates in the adult critically ill patient population.   
Keywords: daily chlorhexidine gluconate bathing, central line associated bloodstream 
infections (CLABSI), methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-
resistant Enterococcus (VRE) or Acinetobacter baumanniic skin colonization acquisition 
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Chlorhexidine Gluconate Bathing an Adjunct Therapy in Reducing Central Line Associated 
Blood Stream Infections: A Literature Review 
    An estimated 1.7 million hospital-associated infections (HAIs) occur in United States 
hospitals annually, resulting in approximately 100,000 deaths and a cost of up to $45 billion  
(Klevens, 2007; Scott, 2009; Umscheid et al., 2011).  According to the Center for Disease 
Control and Prevention (CDC; 2011a), HAI’s are the most common adverse events encountered 
by hospitalized patients, with estimates of one out of twenty patients affected.  Forty-eight 
percent of intensive care unit (ICU) patients have central venous lines, accounting for about 15 
million central venous catheter days per year (Institute for Healthcare Improvement, 2012). 
Central line associated blood stream infections (CLABSIs) are one of the deadliest types of HAI 
with a mortality rate near 18%, and are the source of considerable morbidity and increased health 
care costs (CDC, 2011; Burke, 2003; Glance et al., 2011).  The CDC (2011a) defines a CLABSI 
as a hospital-acquired infection where a primary bloodstream infection develops in a patient who 
had documented presence of a central venous line at the time of infection or within the preceding 
48 hours. The infection cannot be related to any other infectious process and cannot be present or 
incubating upon patient hospital admission.  
Historically, most infection prevention and control measures have focused on aseptic 
technique of healthcare providers and in the management of environment (Agency for 
Healthcare Research and Quality, 2010). Central line associated bloodstream infection 
prevention attempts have included using evidence-based practices at the time of central venous 
line insertion, along with novel strategies including antibiotic or antiseptic-coated catheters and 
antiseptic dressings. The recent shift towards evidence-based practice has many healthcare 
organizations adopting new practices that are aimed at improving patient outcomes and 
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decreasing healthcare costs. The CDC (2011b) reported major reductions in CLABSI rates in the 
U.S. ICUs from 2001 to 2009; this was based upon data submitted to the CDC’s National 
Healthcare Safety Network (NHSN) from healthcare institutions nationwide. An estimated 
43,000 CLABSIs occurred among U.S. ICU patients in 2001, compared with 18,000 in 2009, a 
58% reduction (Srinivasan, 2011). Due to the significant reduction in CLABSI rates, the 
implementation of various prevention initiatives has fostered the idea that CLABSIs are largely 
preventable, and that a CLABSI rate of zero is an achievable goal.  
The recent increase in multi-drug resistant organisms (MDRO) intensifies the scrutiny for 
CLABSI prevention practices.  Infections caused by multi-drug resistant organisms, such as 
methicillin-resistant Staphylococcus aureus (MRSA), multi-drug resistant Acinetobacter 
baumannii, and vancomycin-resistant Enterococcus (VRE), limit the number of effective 
antibiotics available for treatment, prolong hospital lengths of stay and increase cost, patient 
morbidity and mortality. The idea that these infections may be preventable has spurred interest in 
the development of novel strategies and adjunct therapies to reduce infection rates. A major 
mechanism underlying the development of a CLABSI particularly with short-term devices in 
place for ten days or fewer, is the extra-luminal route, where skin microorganisms invade the 
percutaneous tract (Sadfar & Malki, 2004).  One intervnetion strategy is daily whole body patient 
bathing with chlorhexidine gluconate (CHG). Chlorhexidine gluconate a topical antiseptic has 
been used as decolonization therapy to control cross infections (Wendt, et al., 2007). It also has 
broad-spectrum antimicrobial effects and has been used to disinfect the skin for surgical 
procedures and intravascular catheter insertion (Milstone et al., 2008).  Chlorhexidine gluconate 
has an excellent safety profile and proven efficacy over a wide spectrum of gram-positive and 
gram-negative bacteria, as well as fungi and some viruses (Lin & Hayden, 2010). Unlike many 
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other antiseptics, CHG has residual antibacterial activity, which may reduce the microbial 
colonization of the patient’s skin and prevent secondary environmental contamination (Milstone, 
Passaretti, & Perl, 2008). 
Research indicates that daily bathing with two percent CHG-impregnated cloths 
decreases patient bacterial skin colonization, healthcare workers’ hand contamination, and 
environmental surface contamination (Vernon et al., 2006). Daily cleansing of ICU patients’ skin 
with CHG has been associated with reduced incidence of colonization’s with VRE, 
MRSA(Climo et al., 2009; Vernon et al., 2006), and multi-drug resistant Acinetobacter 
baumannii (Borer et al. 2007; Evans et al. 2010) and has been linked with decreased incidence of 
CLABSIs due to VRE and MDR Acinetobacter baumannii (Bleasdale et al., 2007; Borer et al., 
2007; Popovich et al., 2009).  
Research Question (PICO) 
 
The development of a well-framed and defined research question is the foundation to 
conducting quality research (Stern, C., Zoe, J. & McArthur A., 2014).  Using a defined 
PICO question will lead to an appropriate study design and methodology, and is an essential part 
of the evidence review process. The formation of a PICO question is the first step in the evidence 
based practice process and includes the following components: (a) patient population; (b) 
intervention or area of interest; (c) comparison intervention or comparison group; and (d) 
outcomes. The following PICO question will serve as a guide for extracting the best evidence 
from current literature and facilitate evidence-based practice (Fineout-Overholt, Melnyk, & 
Schultz, 2005). 
Does daily whole body patient bathing using chlorhexidne gluconate in the critically ill 
adult population impact central line associated blood stream infection (CLABSI) rates compared 
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to traditional daily soap and water bathing? 
Methods 
Using a predefined strategy to identify the most current and relevant research 
articles from the literature, a comprehensive search of the Cumulative Index of 
Nursing and Allied Health Literature (CINAHL), Medical Literature Analysis and Retrieval 
System Online (MEDline), and PubMed databases was conducted using various 
combinations of the following key words: central line associated blood stream infections 
(CLABSIs); chlorhexidine gluconate, daily bathing, methicillin-resistant Staphylococcus aureus 
(MRSA), Vancomycin-resistant Enterococcus (VRE) or Acinetobacter baumanniic colonization/ 
acquisition used. Along with these searches, a manual review of reference lists was completed on 
the relevant published articles.  
The goal of this review was to identify published clinical research to determine 
the potential impact of daily CHG whole body patient bathing  on the prevention of CLABSIs. 
Inclusion criteria were as follows: full-text, peer reviewed nursing or medical journal articles 
published in English after the year 2000. Articles involving the study of critically ill human 
subjects 18 years of age or older were included in this review. Articles that dealt with 
decolonization strategies other than CHG bathing were excluded. Article titles and abstracts were 
sorted and literature relevant to the topic of daily whole body chlorhexidine bathing in the adult 
critically ill patient population was evaluated. The database search ultimately resulted in the 
selection of eight research articles (see Table 1). 
Summary of Findings  
The eight articles reviewed included one randomized control trial, one non-randomized 
clinical trial, one observational cohort with historical controls and five quasi-experimental 
15 
 
 
 
designs. The study settings were in a variety of critical care specialty areas, both medical and 
surgical.  Hospital sizes ranged from community medical centers to large tertiary level one 
trauma centers. All studies evaluated the impact of using 2% CHG impregnated non-rinse cloths 
with the traditional soap-and-water bath basin technique. All but one out of the eight studies 
found a statistically significant reduction in CLABSIs with the introduction of CHG daily patient 
bathing.   
A clinical trial of 836 patients using concurrent controls and a crossover design 
investigated whether CHG cleansing would decrease the incidence of primary blood stream 
infections (BSIs) compared with traditional soap and water baths in two medical ICUs 
(Bleasdale et al., 2007).  Patients in the CHG arm were 61% less likely to acquire a primary BSI. 
Patients receiving the CHG bathing intervention compared to the traditional soap and water 
bathing were at a significantly lower risk of developing a CLABSI (6.4 vs. 16.8 BSIs per 100 
central line-days; P=.01).  Montecalvo et al. (2012) conducted a prospective, 3-phase study in 
both medical and surgical ICUs in four community hospitals totally 21,022 central venous 
catheter days. Pre-intervention (phase 1) patients were bathed with soap and water; intervention 
(phase 2) patients were bathed with two percent CHG impregnated cloths; post-intervention 
(phase 3) CHG bathing was continued but without oversight by research personnel. Study 
analysis included CLABSI rates compared over study periods using Poisson regression. 
Compared with pre-intervention, during active intervention there were significantly fewer 
CLABSIs (6.4 vs. 2.6 per 1000 central venous catheter days, relative risk; P<.001), and this 
reduction was sustained during post-intervention (2.9 per 1000 central venous catheter days; 
relative risk; P<.001). 
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Popovich et al. (2009, 2010) conducted two quasi-experimental studies, one in a medical 
population and the other in a surgical population.  Popovich et al. (2009) evaluated the use of 2% 
impregnated CHG cloths versus soap and water for daily bathing in 318 patients in a 21-bed 
MICU at Rush University. The results showed a significant decrease in CLABSI rates (from 5.31 
to 0.69 cases per 1,000 central line days; P= .006), along with blood culture contaminations, but 
no significant change in rates of secondary blood stream infections, ventilator associated 
pneumonia, or urinary tract infections.  Popovich et al. (2010) used a surgical ICU setting to test 
the use of daily CHG bathing versus traditional soap and water. In a sample of 254 patients 
results showed no significant difference in the CLABSI rate between soap-and-water and CHG 
bathing periods (3.81 to 4.6 per 1,000 central line days; p = 0.57). However, blood culture 
contamination significantly decreased, suggesting that the microbial burden on the skin was 
reduced. The authors addressed this finding by pointing out that surgical ICU patients more often 
have large, open abdominal wounds. These serve as a source for healthcare worker 
contaminations and translocation of bacteria into the bloodstream, causing possible 
misidentification of positive blood cultures as CLABSIs. 
Evans et al. (2010) demonstrated that bathing trauma patients in the ICU with 2% CHG 
impregnated cloths versus soap and water decreased rate of colonization of MRSA and 
Acinetobacter baumannii, significantly lowered rates of CLABSIs, and MRSA ventilator 
associated pneumonia versus the soap and water group in 539 patients. The patients receiving the 
CHG daily bathing intervention demonstrated a significantly lower risk in developing a CLABSI 
from the control group (2.1 vs. 8.4 infections per 1000 catheter days; P=0.01).  An observational 
cohort study design using historical controls at a Level I trauma center evaluated effectiveness of 
a quality improvement intervention protocol implementing daily cleansing with CHG cloths 
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versus soap and water in144 patients. The results included a CLABSI rate reduction of 73.7% 
(12.07 to 3.17 CLABSIs per 1000 central line-days; P=.0358; Dixon & Carver, 2010). Another 
quality improvement initiative utilizing daily CHG bathing versus soap and water in efforts to 
reduce CLABSI rates was conducted at Emory University Hospital (Holder & Zellinger, 2009). 
A six-month before and after design was used; CLABSI rates decreased from 1.6 to 0.73 in the 
cardiovascular ICU, from 4.39 to 0.83 in one medical ICU, and from 2.35 to 0.78 in the second 
medical ICU. Overall both the CLABSI reduction rate and MRSA/VRE colonization incidence 
decreased from 3.6 to 1 per 1,000 patient days upon initiation of daily CHG patient bathing.  
A large multicenter, cluster-randomized, non-blinded crossover trial of 7,727 patients 
investigated the effect of daily bathing with CHG impregnated cloths versus soap and water on 
the acquisition of MDROs and the incidence of hospital-acquired bloodstream infections (Climo 
et al., 2013).  Overall the rate of MDRO acquisition decreased 23% between intervention and 
control group (5.10 versus 6.60 cases per 1000 patient –days; P=.03) and rate of hospital-
acquired bloodstream infection reduction of 28% (4.78 vs. 6.60 cases per 1000 patient-days; 
P=0.007).The analysis showed a 53% reduction (1.55 vs. 3.30 cases per 1000 catheter-days, 
P0.004) in CLABSI rates between the intervention and control (Climo et al., 2013). In this 
multicenter study consisting of various medical and surgical ICUs a secondary analysis 
examined whether the reductions in bloodstream infection rates were related to the type of unit. 
There were no significant variations between the type of unit and the development of 
bloodstream infections, suggesting that daily CHG bathing may be beneficial in a range of 
settings. 
With the use of any medication or solution, the occurrences of adverse reactions or side 
effects are major concerns. Four out of the eight studies addressed adverse reactions linked with 
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the use of CHG to patient rash, breakdown, or allergic reactions. In Climo et al. (2013), the 
overall incidence of skin reactions among patients assigned to CHG bathing group was 2.0% (78 
of 3970 patients). All skin reactions were ruled to be unrelated to the bathing interventions, and 
overall, 85% of the reactions were classified as mild to moderate. During the study conducted by 
Bleasdale et al. (2007) only three out of the three hundred ninety one patients in the CHG arm 
developed a skin reaction but all were ultimately attributed to other factors. Evans et al. (2010) 
reported only two rashes during the interventions period, both of which were attributed to 
antibiotic therapy and resolved without treatment. Chlorhexidine gluconate bathing was 
discontinued in three patients because of skin rash and restarted in two of the three patients 
without adverse event; the third patient also had thrombocytopenia that resolved with stopping 
multiple medications and chlorhexidine (Montecalvo et. al, 2012).  In total all reactions were 
eventually attributed to other factors and no major adverse reactions were reported. 
The routine and frequent use of CHG bathing may raise concerns about promoting the 
emergence of CHG resistance organisms. Only two of the eight studies explored the possibility 
of CHG resistance. In Bleasdale et al. (2007) no isolates obtained demonstrated significant CHG 
resistance. In Climo et al. (2013) no emergence of MRSA or VRE isolates with high-level 
resistance were identified. In the remaining reviewed studies, resistance was not addressed. The 
potential for the development of resistance to CHG remains a significant concern and should be 
examined over time. 
Cost Analysis  
Although no formal cost analysis was undertaken in any studies reviewed or currently 
available in the literature.  Some studies address cost, which in the state of today’s economy is 
essential for both organizational and patient financial well-being. Climo (2009) identified the use 
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of CHG as a low cost solution for infection control. However, this study used CHG solution 
mixed in basins, versus the other studies that utilized the CHG impregnated cloths, which would 
be basin free. It has also been suggested that bath basins may be a reservoirs of pathogenic 
microbes, and the link in transmission of such pathogens (Milstone, Passaretti, & Perl, 2008).  
Although,  the cost of chlorhexidine cloths is greater than  non-chlorhexidine cloths ($5.50 vs 
$1.46 per bath), due to the 75% reduction  in CLABSIs over a six month period of time, a 
projected calculated cost savings of $1.56 million per  year was estimated, if CHG baths were 
used in all of the study hospital’s ICUs ( Holder & Zellinger, 2009).  There was no statistical 
difference found in cost between bathing using 2% CHG-impregnated cloths ($7.85 per patient 
per day) versus the four percent CHG solution basin bath ($5.22 per patient per day), although a 
statistically significant decrease in nursing time to administer the bath was observed with CHG-
impregnated cloth (p =0.008; Ritz et al., 2011). Evans et al. (2010) estimated the cost of CHG 
impregnated cloths to be $5.52 per bath at the time of the trial as opposed to $1.23 per bath for a 
disposable bathing product that does not contain CHG. Dixon and Carver (2010) identified a 
$728,820 cost savings using two percent CHG-impregnated cloths versus traditional soap and 
water within seventeen months of use. After calculating the difference between the increased 
expenditure of switching to CHG impregnated cloth bathing there was an equivalent to a savings 
of $945,000, which was more than ten times the cost of chlorhexidine, bathing (Montecalvo et 
al., 2012).   
Implications for Practice  
Poor compliance with hand hygiene, reluctance to adopt barrier precautions owing to 
unintended consequences of isolation, and controversy over the cost-effectiveness and feasibility 
of legislated universal surveillance have been barriers to effective infection control (Agency for 
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Healthcare Research and Quality, 2010). Furthermore, while these methods (when practiced 
consistently) may prevent transmission to other patients, they confer little or no protection to the 
patient who becomes colonized with the resistant organism. While chlorhexidine bathing should 
not be considered a replacement for contact precautions, use of a routine decontamination-
bathing regimen can decrease the potential for organism transmission even before results of 
surveillance testing are available. Furthermore, in a recent epidemiologic investigation of the 
impact of universal active surveillance for MRSA conducted in an academic medical center with 
a long history of comprehensive infection-control practices, more than half of MRSA 
colonization’s were demonstrated to occur after a negative surveillance culture was confirmed on 
admission, suggesting that there is room for potential benefit from daily inpatient 
decontamination procedures in addition to the current infection-control efforts (Harbarth, 2008). 
Limited but promising studies have demonstrated that daily CHG bathing is an option to 
reduce HAIs and bacterial colonization on patients’ skin, especially in patients in the ICU 
(Bleasdale et al., 2007; Popovich et al. 2010 ; Holder & Zellinger, 2009; Evans et al. 2010; 
Dixon & Carver, 2010;  Climo et al., 2013; Montecalvo et. al, 2012). The Healthcare Infection 
Control Practices Advisory Committee (HICPAC) of the Centers for Disease Control and 
Prevention published revised CLABSI-prevention guidelines in 2011. The 2011 guideline for 
prevention of intravascular catheter related infections by the Centers for Disease Control and 
Prevention includes a category II recommendation for daily bathing with two percent CHG 
(O’Grady et al., 2011). 
Implications for Future Research  
As CLABSIs and other healthcare-associated blood stream infections are becoming 
increasingly more prominent outside the ICU, the use of CHG daily bathing should also be 
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examined in the non-ICU setting (Climo et al., 2013). Additional considerations in this 
noncritical population should include a careful assessment of adverse effects, such as patient 
reports of skin dryness and irritation. A recommendation for further nursing research would 
include future studies to evaluate the effectiveness and feasibility of CHG bathing in non-ICU 
settings.  
Follow up studies are also needed within various ICU settings, including surgical versus 
non-surgical, patients receiving immunosuppressant therapy, and invasive equipment, along with 
the potential benefits of this intervention on blood-culture contamination rate, use of antibiotic 
agents, and mortality. There are several different types of central venous line access devices 
including non-tunneled, tunneled, implantable ports, and peripherally inserted central catheters. 
An area for future research is to evaluate effectiveness of CHG bathing in the prevention of 
CLABSIs based on type of central venous line access device.  
 A delicate balance must be achieved between the rigorous regulatory oversight inherent 
in the traditional research model, and the necessity for innovative quality-improvement 
initiatives, such that novel products can be tested in high-risk populations, including children. 
Avoiding overuse of CHG in settings where it has not been proven to have benefit may be 
especially prudent with the possibility of CHG organism resistance.  
Conclusion 
Identifying simple, cost-effective, and safe strategies for the prevention of health care–
associated infection is essential. Daily bathing with CHG impregnated cloths is a strategy that is 
relatively straightforward to implement and sustain because it does not require a substantial 
change from patient-bathing practices that are currently routine. Daily bathing with 2% CHG 
impregnated cloths as an adjunct therapy in the prevention of CLABSIs is promising. The 
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evidence is strongest for MICU patients; a trial conducted solely in a surgical ICU did not find a 
benefit with CHG bathing. The majority of the studies were quasi-experimental, with little to no 
assessment of or adjustment for confounding variables. While no formal cost analysis was done, the 
low cost of CHG compared with the high cost of even a single CLABSI suggests that CHG 
bathing likely saves costs. In conclusion, existing data largely obtained from a single randomized 
clinical trial, a non-randomized controlled trial and quasi-experimental designs support the practice of 
daily bathing with 2% CHG impregnated cloths for the reductions of CLABSIs.  
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Table 1 Summary of reviewed articles 
Author  
 
Study Design Sample/Setting Purpose Findings  
  Bleasdale, S.C., Trick, W.E., 
Gonzalez, I.M., Lyles, R.D., 
Hayden, M.K., & Weinstein, 
R.A. (2007). Effectiveness of 
chlorhexidine bathing to reduce 
catheter-associated bloodstream 
infections in medical intensive 
care unit patients. Archives 
Internal Medicine, 167(19), 
2073-2079. 
Cross-over 
(concurrent 
control group) 
Clinical Trial 
  
836 
patients/MICU 
Determine if 
patients bathed 
daily with 2% 
CHG cloths have 
a lower 
incidence of 
primary 
bloodstream 
infections (BSI) 
compared to 
those bathed in 
soap & water  
Patients in the CHG 
arm were 61% less 
likely to acquire a 
primary BSI compared 
to soap & water 
group. Patients in the 
CHG arm were at a 
lower risk of CLABSI 
(6.4 vs 16.8 BSIs per 
1000 central line-
days; P=.01)  
Dixon, J.M., & Carver, R.L. 
(2010). Daily chlorhexidine 
gluconate bathing with 
impregnated cloths results in 
statistically significant reduction 
in central line-associated 
bloodstream infections. 
American Journal of Infection 
Control, 38 (8), 17-21. doi: 
10.1016/j.ajic.2010.06.005 
Observational 
Cohort with 
Historical 
Controls 
144 
patients/SICU 
Evaluate a 
quality 
improvement  
protocol 
instituted to 
reduce CLABSI 
rates with a 3-
month 
effectiveness 
study using 2% 
CHG cloths for 
daily bathing 
A decrease in 
CLABSI rates from 
12.07 per 1000 central 
line days to 3.17 
CLABSIs per 1000 
central line-days 
(73.3% rate reduction; 
P = .0358) 
Climo, M., Yokoe, D., Warren, 
D., Perl, T., Bolon, M., 
Herwaldt, L., & Weinsten, R.A.,  
Sepkowitz, K.A., Jernigan, J.A., 
Sanogo, K., & Wong, E. (2013).  
Effect of daily chlorhexidine 
bathing on hospital-acquired 
infection. New England Journal 
Of Medicine, 368(6), 533-542. 
doi:10.1056/NEJMoa1113849 
Cluster-
randomized, 
nonblinded 
crossover trial  
7727 patients/ 
MICU, CCU, 
SICU, CTICU 
Evaluate the 
effectiveness of 
bathing patient 
with 2% CHG 
cloths in 
reducing the risk 
of MDRO 
acquisition & 
hospital acquired 
bloodstream 
infections 
CLABSIs rates 
decreased by 53% 
during intervention 
period compared to 
control (3.61 vs. 5.24 
cases per 1000 patient 
days, P=0.004). 
Overall HAI rates 
decreased 28% & 
MDRO acquisition 
decreased 23% after 
CHG bathing.  
Evans, H.L., Dellit, T.H., Chan, 
J., Nathens, A.B., Maier, R.V., & 
Cuschieri, J. (2010). Effect of 
chlorhexidine whole-body 
bathing on hospital-acquired 
infections among trauma 
patients, Archives of Surgery, 
145(3), 240-246. 
 
 
 
Before and 
after study   
TICU/ 539 total 
patients 
Determine if 
daily bathing 
with 2% CHG 
cloths would 
decrease 
colonization & 
HAIs of resistant 
bacteria in 
trauma patients 
 
Pts. receiving CHG 
baths were 
significantly less 
likely to acquire a 
CLABSI (2.1 vs 8.4 
infections per 1000 
catheter-days; P=.01), 
incidence of VAP was 
not affected by CHG 
baths however, pts. 
were less likely to 
develop MRSA VAP, 
Colonization of 
MRSA & 
Acinetobacter were 
significantly lower in 
the CHG group than 
in the comparison 
group 
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Note. CHG=Chlorhexidine Gluconate; HAI=hospital acquired infections; MRSA= methicillin-resistant 
Staphylococcus aureus; VRE= vancomycin-resistant Enterococcus; CVC= Central venous catheter; BSI= blood 
stream infection; VAP=ventilator associated pneumonia; UTI; urinary tract infection; MICU=medical intensive care 
unit; TICU=trauma intensive care unit; SICU=surgical intensive care unit; CCU=coronary care unit; 
CVSICU=cardio vascular surgical intensive care unit, CLABSI= Central line associated blood stream infection 
CDI=Clostridium difficile infection, NR=Not Reported 
Author  
 
Study Design Sample/Setting Purpose Findings  
Holder C. & Zellinger M. (2009) 
Daily bathing with chlorhexidine 
in the ICU to prevent central 
line-associated bloodstream 
infections. Journal of Clinical 
Outcomes Management, 16, 509-
513. 
Before and 
after study  
NR/MICU/ 
CTICU  
Evaluate quality 
improvement 
initiative to 
reduce CLABSI 
rates using CHG 
wipes for daily 
bathing  
CLABSI rates 
decreased from 3.6 to 
1 per 1000 patient 
days; Rate of 
MRSA/VRE 
colonization  
decreased from 3.6 to 
1 per 1000 patient 
days 
Montecalvo, M., McKenna, D., 
Yarrish, R., Mack, L., Maguire, 
G., Haas, J.,  DeLorenzo, L.,  
Dellarocco, N., Savatteri, B., 
Rosenthal, A., Watson, A., 
Spicehandler, D., Shi, Q., 
Visintainer, P. & Wormser, G. 
(2012). Chlorhexidine bathing to 
reduce central venous catheter-
associated bloodstream infection: 
impact and sustainability. The 
American Journal Of Medicine, 
125(5), 505-511. 
doi:10.1016/j.amjmed.2011.10.0
32 
Before and 
after study   
21,022 Central 
Venous Catheter 
Days/MICU, 
SICU 
Determine the 
impact & 
sustainability of 
daily patient 
bathing with 2% 
CHG cloths on 
CLABSI rates  
CLABSI rates 6.4 
versus 2.6 per 1000 
central venous 
catheter days  
Popovich, K.J., Hota, B., Hayes, 
R., Weinstein, R.A., & Hayden, 
M.K. (2009). Effectiveness of  
routine patient cleansing with 
chlorhexidine gluconate for 
infection prevention in the 
medical intensive care unit. 
Infection Control and Hospital 
Epidemiology, 30(10), 959-963. 
doi: 10.1086/605925 
Before and 
after study  
318 patients/ 
MICU 
To examine 
effectiveness of 
cleansing 
patients with 2% 
CHG cloths in 
reducing rates of 
CLABSI 
CLABSIs decreased 
from  (5.31 to 0.69 
cases per 1000 central 
line days; P=.006) 
from soap/water 
bathing to CHG 
bathing. Additional 
outcomes included a 
decline in blood 
culture contamination 
rate in CHG group. 
Secondary BSI, CDI, 
VAP, & UTI rates did 
not change between 
CHG & soap/water 
groups 
Popovich, K.J., Hota, B., Hayes, 
R., Weinstein, R.A., & Hayden, 
M.K. (2010). Daily skin  
cleansing with chlorhexidine did 
not reduce the rate of central-line 
associated bloodstream infection 
in a surgical intensive care unit. 
Intensive Care Medicine, 36(5), 
854-858. doi: 10.1007/s00134-
010-1783-y 
Before and 
after study  
254 patients 
/SICU 
To evaluate the 
effect of daily 
2% CHG cloth 
bathing on 
CLABSI rates 
No significant 
difference in the rates 
of CLABSI in the 
soap-and-water versus 
CHG periods were 
noted (4.6 vs. 3.81 per 
1,000 central line 
days), blood culture 
contamination rates 
declined significantly 
25 
 
Running Head: CHLORHEXIDINE GLUCONATE BATHING   
References 
Agency for Healthcare Research and Quality (2010). Agency for Healthcare Research and  
 
Quality (AHRQ) efforts to prevent and reduce health care-associated infections.  
 
Rockville, MD: AHRQ. Retrieved from: http://www.ahrq.gov/qual/haiflyer.htm 
 
Baily, R. Stucky, D. Norman, B, Duggan, A., Bacon, K., Connor, D., & Lee, B. (2011).  
Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to 
prevent surgical site infection. Infection Control and Hospital Epidemiology, 32, 465-
471.  
Bleasdale, S.C., Trick, W.E., Gonzalez, I.M., Lyles, R.D., Hayden, M.K., & Weinstein, R.A.  
(2007). Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream 
infections in medical intensive care unit patients. Archives Internal Medicine, 167(19), 
2073-2079. 
Burke, J.P. (2003). Infection control a problem for patient safety. New England Journal  
of Medicine, 348, 651-656.  
Center for Disease Control & Prevention. (2011a). 2011 Guidelines for the prevention of  
 
intravascular catheter-related infections. Retrieved from  
 
http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html  
Center for Disease Control & Prevention. (2011b). Vital signs: Central line-associated blood  
stream infections, United States, 2001,2008, & 2009. Morbidity & Mortality Weekly 
Report, 60, 1-6. 
Climo, M., Diekema, D., Warren, D.K., Herwarldt, L.A., Perl, T.M., Peterson, L., Plskett, T.,  
 
Sepkowitz, K., Solomon, S., Tokars, J., Fraser, V.J., & Wong, E. (2003). Prevalence of  
 
the use of central venous access devices within and outside of the intensive care unit:  
 
 
 
 
 
results of a survey among hospitals in the prevention epicenter program of the Centers for  
 
Disease Control and Prevention. Infection Control & Hospital Epidemiology, 24(12),  
 
942–945. 
 
Climo, M.W., Sepkowitz, K.A., Zuccotti, G., Fraser, V.J., Warren, D.K., Perl, T.M., Speck, K.,  
Jernigan, J.A., Robles, J.R., & Wong, E.S. (2009). The effect of daily bathing with 
chlorhexidine on the acquisition of methicillin-resistant staphylococcus aureus, 
vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: 
Results of a quasi-experimental multicenter trial. Critical Care Medicine, 37(6), 1858-
1865. doi:10.1097/CCM.0b013e31819ffe6 
Climo, M., Yokoe, D., Warren, D., Perl, T., Bolon, M., Herwaldt, L., & Weinsten, R.A.,  
Sepkowitz, K.A., Jernigan, J.A., Sanogo, K., & Wong, E. (2013).  
Effect of daily chlorhexidine bathing on hospital-acquired infection. New England 
Journal Of Medicine, 368(6), 533-542. doi:10.1056/NEJMoa1113849 
Dixon, J.M., & Carver, R.L. (2010). Daily chlorhexidine gluconate bathing with impregnated  
cloths results in statistically significant reduction in central line-associated bloodstream 
infections. American Journal of Infection Control, 38 (8), 17-21. doi: 
10.1016/j.ajic.2010.06.005 
Evans, H.L., Dellit, T.H., Chan, J., Nathens, A.B., Maier, R.V., & Cuschieri, J.  
 (2010). Effect of chlorhexidine whole-body bathing on hospital-acquired infections among  
 trauma patients, Archives of Surgery, 145(3), 240-246. 
Fineout-Overholt, E., Melnyk, B. M., & Schultz, A. (2005). Transforming Health Care from the 
Inside Out: Advancing Evidence-Based Practice in the 21st Century. Journal of 
Professional Nursing, 21, 335-344. 
27 
 
 
 
Glance, L.G., Stone, P.W., Mukamel, D.B., & Dick, A.W. (2011). Increase in mortality, length  
 of stay, and cost associated with hospital-acquired infections in trauma patients. Archives  
 of Surgery, 146(7), 794-801. doi: 10.1001/archsurg.2011.41 
Harbarth, S., Fankhauser, C., Schrenzel, J., Christenson, J., Gervaz, P., Bandiera-Clerc, C.,  
Renzi, G., Vernaz, N., Sax, H., & Pittet, D. (2008). Universal screening for methicillin-
resistant staphylococcus aureus at hospital admission and nosocomial infection in surgical 
patients. Journal of the American Medical Association, 299(10), 1149-1157. doi: 
10.1001/jama.299.10.1149  
Hibiclens [material safety data sheet]. Wilmington, DE: ICI Americas, 1987. 
Hidron, A.I., Edwards, J.R., Patel, J., Horan, T.C., Sievert, D.M., Pollock, D.A., & Fridkin S.K.  
(2008). Antimicrobial-resistant pathogens associated with healthcare-associated infections: 
Annual summary of data reported to the national healthcare safety network at the centers 
for disease control and prevention, 2006–2007. Infection Control and Hospital 
Epidemiology, 29 (11), 996-1011. doi: 10.1086/591861 
Holder, C. and Zellinger M. (2009). Daily bathing with chlorhexidine in the ICU to prevent  
central line-associated bloodstream infections. Journal of Clinical Outcomes Management, 
16(11), 509-513. 
Institute of Medicine. (2011). The future of nursing: Leading change, advancing health. 
Retrieved from http://www.nap.edu/catalog/12956.html 
Instituate for Healthcare Improvement. (2012). How-to Guide: Prevent Central Line-Associated  
Bloodstream Infections. Cambridge, MA: Institute for Healthcare Improvement. Retrieved 
from www.ihi.org  
Klevens, M.R., Edwards, J.R., Richards, C.L., Horan, T.C., Gaynes, P.R., Pollock, D.A., &  
28 
 
 
 
Cardo, D.M. (2007). Estimating health care-associated infections and deaths in U.S. 
hospitals, 2002. Public Health Reports, 122, 160-166. 
Lin, M.Y., Hayden, M.K., (2010). Methicillin-resistant Staphylococcus aureus and vancomycin- 
 resistant Enterococcus: Recognition and prevention in intensive care units. Critical Care  
 Medicine, 38(8), 335–344.  
Merrer, J., Santoli, F., Vecchi, C.A., Tran, B., De Jonghe, B., & Outin, H. (2000). “Colonization  
pressure” and risk of acquisition of methicillin-resistant staphylococcus aureus in a 
medical intensive care unit. Infection Control and Hospital Epidemiology, 21(11), 718-
723.  
Milstone, A.M., Passaretti, C.L., & Perl, T.M. (2008). Chlorhexidine: Expanding the  
armamentarium for infection control and prevention. Clinical Infectious Disease, 46 (2), 
274-281. doi: 10.1086/524736  
Nelson, R.E., Samore, M.G., Smith, K.J. Harbarth, S., & Rubin, M.A. (2010). Cost-effectiveness  
of adding decolonization to a surveillance strategy of screening and isolation for 
methicillin-resistant Staphylococcus aureus carriers. Clinical Microbiology and Infection, 
16, 1740-1746.  
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., & …  
Saint, S. (2011). Guidelines for the prevention of intravascular catheter-related infections. 
American Journal Of Infection Control, 39(4), 1-34. doi:10.1016/j.ajic.2011.01.003 
O’Horo, J.C., Silva, G.L.M, Munoz-Price, S., & Safdar, N. (2012). The efficacy of daily bathing  
with chlorhexidine for reducing healthcare-associated bloodstream infections: A meta- 
analysis. Infection Control and Hospital Epidemiology, 33(3), 257-267. doi: 
10.1086/664496 
29 
 
 
 
Montecalvo, M., McKenna, D., Yarrish, R., Mack, L., Maguire, G., Haas, J.,  DeLorenzo, L.,  
Dellarocco, N., Savatteri, B., Rosenthal, A., Watson, A., Spicehandler, D., Shi, Q., 
Visintainer, P. & Wormser, G. (2012). Chlorhexidine bathing to reduce central venous 
catheter-associated bloodstream infection: impact and sustainability. The American 
Journal Of Medicine, 125(5), 505-511. doi:10.1016/j.amjmed.2011.10.032 
Popovich, K.J., Hota, B., Hayes, R., Weinstein, R.A., & Hayden, M.K. (2009). Effectiveness of  
routine patient cleansing with chlorhexidine gluconate for infection prevention in the 
medical intensive care unit. Infection Control and Hospital Epidemiology, 30(10), 959-
963. doi: 10.1086/605925 
Popovich, K.J., Hota, B., Hayes, R., Weinstein, R.A., & Hayden, M.K. (2010). Daily skin  
cleansing with chlorhexidine did not reduce the rate of central-line associated 
bloodstream infection in a surgical intensive care unit. Intensive Care Medicine, 36(5), 
854-858. doi: 10.1007/s00134-010-1783-y 
Ritz, J., Pashnik, B., Padula, C., & Simmons, K. (2011). Effectiveness of two method of  
chlorhexidine bathing. Journal of Nursing Care Quality, 27, 171-175.  
Safdar, N., & Maki, D.G. (2004). The pathogenesis of catheter-related blood-stream infection  
 
with noncuffed short-term central venous catheters. Intensive Care Medicine, 30(1), 62– 
 
67. 
 
Sare, M. & Ogilvie, L. (2010).  Strategic planning for nurses: Change management in 
 
health care.  Jones and Bartlet: Sudbury, MA. 
 
Schein, E. H. (2010). Organizational culture and leadership. (4th ed.). San Francisco:  
 
Jossey-Bass. 
 
Scott II, D.R. (2009) The direct medical costs of healthcare-associated infections in U.S.           
30 
 
 
 
hospitals and the benefits of prevention. Center for Disease Control and Prevention, 
Division of Healthcare and Quality Promotion.  
Stern, C. (2014). Developing the Review Question and Inclusion Criteria. American Journal Of  
Nursing, 114(4), 53. 
Stone, P.W., Braccia, D.,  & Larson, E. (2005). Systematic review of economic analyses of  
 
health care-associated infections. American Journal of Infection Control, 33(9), 501–509.  
 
Umscheid CA, Mitchell MD, Doshi JA, Agarwal R, Williams K, Brennan PJ. (2011).Estimating  
 
the proportion of healthcare-associated infections that are reasonably preventable and the  
 
related mortality and costs. Infection Control & Hospital Epidemiology, 32(2), 101– 
 
114. 
 
University of Kentucky Hospital. (2013). Central venous catheter maintenance bundle #NI08- 
 
25. Retrieved from Employee CareWeb: UK Healthcare Policy Web on Decemeber 02,  
 
2013. 
 
Vernon, M.O., Hayden, M.K., William, T.E., Hayes, R.A., Blom, D.W., & Weinstein, R.A.  
(2006). Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: The 
effectiveness of source control to reduce the bioburden of vancomycin resistant 
enterococci. Archives of Internal Medicine, 166(3), 306-312.  
Wendt, C., Schinke, S., Wurttemberger, M., Oberdorfer, K., Bock-Hensley, O., von Baum H.  
(2007). Value of whole-body washing with chlorhexidine for the eradication of methicillin-
resistant Staphylococcus aureus. Infection Control & Hospital Epidemiology, 28(9), 1036–
1043.  
Wolf, Z.R. (1993). The bath: A nursing ritual. Journal of Holistic Nursing, 11(2), 135-148. 
 
31 
 
 
 
Yukl, G. (2010). Leadership in Organizations. Upper Saddle River, NJ: Pearson  
Education, Inc.  
Zaccheo, M. M., & Bucher, D. H. (2010). Establishing evidence-based transfusion education for 
best practice. Nursing 2010 Critical Care, 5, 41-44. 
doi.org/10.1097/01.CCN0000387740.50994.9c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
32 
 
 
 
 
Manuscript 2 
 
 
 
 
     Quantifying the Value of Daily Bathing with Chlorhexidine Gluconate Impregnated Cloths 
 
 
 
 
Kara A. Willett BSN, RN, CCRN  
University of Kentucky 
College of Nursing 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
Abstract  
Hospital-acquired infections including central-line associated blood stream infections 
(CLABSIs) are a major concern in today’s health care system.  CLABSIs are a significant source 
of patient mortality, increased length of stay, and healthcare spending.  The heightened 
awareness of these infections along with their escalating cost has amplified implementation of 
preventative protocols.  Organizations are continuously reevaluating routine operating 
procedures and patient care guidelines to assure the delivery of safe and effective care but also 
financially responsible care.  The search for CLABSI prevention strategies with a range of 
benefits, including improved patient outcomes and an overall cost reductions is critical.  The 
purpose of this paper is to review a daily bathing protocol utilizing chlorhexidine gluconate 
impregnated cloths as a CLABSI reduction technique and to explore potential financial worth of 
implementation.  
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Quantifying the Value of Daily Bathing with Chlorhexidine Gluconate 
 Impregnated Cloths 
Hospital-associated infections (HAIs) are a significant cause of morbidity, mortality, and 
increase in healthcare costs (World Healthcare Organization [WHO], 2014).  HAIs affect one out 
of every twenty hospitalized patients at any given time (Klevens, 2007).  Some of the most 
serious HAIs are those that involve the bloodstream.  Central-line associated bloodstream 
infections (CLABSIs) are the most common cause of health care-associated infection in the 
bloodstream (WHO, 2014). Forty-eight percent of intensive care unit (ICU) patients have central 
lines, such as broviac and peripherally inserted central lines, accounting for approximately 15 
million central venous catheter days per year (Institute for Healthcare Improvement, 2012).  
CLABSIs are one of the deadliest types of HAI with a mortality rate near eighteen percent, and 
significantly increased healthcare costs (Centers for Disease Control and Prevention [CDC], 
2011a; Burke, 2003; Glance et al., 2011).  The increased length of hospital stay and risk of 
mortality lead to an additional $39,000 per episode of CLABSI (The Society of Healthcare 
Epidemiology of America, 2014).  
 The recent increase in multi-drug resistant organisms (MDROs) intensifies the scrutiny 
for CLABSI prevention practices.  Infections caused by MDROs, such as methicillin-resistant 
Staphylococcus aureus, multi-drug resistant Acinetobacter baumannii, and vancomycin-resistant 
Enterococcus, limit the number of effective antibiotics available for treatment.  The idea that 
these infections may be preventable has spurred interest in the development of novel strategies 
and adjunct therapies to reduce infection rates.  In the last several years, major changes have 
impacted HAI prevention in U.S. healthcare.  These developments include improved 
interdepartmental coordination of federal efforts aimed at HAI prevention, (US Department of 
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Health and Human Services, 2013) posting of hospital-specific HAI rates on public websites to 
promote transparency, and linking of hospital specific HAI performance to financial 
reimbursement as a strategy to motivate hospitals’ HAI prevention efforts (Centers for Medicare 
and Medicaid Services, 2013).   
Description of Whole Body Patient Bathing with 
 Chlorhexidine Gluconate Impregnated Cloths  
Research indicates that daily bathing with two percent chlorhexidine gluconate (CHG)-
impregnated cloths decreases patient bacterial skin colonization, healthcare workers’ hand 
contamination, and environmental surface contamination (Vernon et al., 2006). CHG is a topical 
antimicrobial agent and a primary ingredient in numerous products including oral rinses, creams, 
lotions, foams, gels, sprays, dressings, and ointment forms.  CHG has broad-spectrum 
antimicrobial effects and is used to disinfect the skin for surgical procedures and intravascular 
catheter insertion (Milstone, Passaretti, & Perl, 2008).  CHG also has an excellent safety profile 
and proven efficacy over a wide spectrum of bacteria, as well as fungi and some viruses (Lin & 
Hayden, 2010). Unlike many other antiseptics, CHG has residual antibacterial activity, which 
may reduce the microbial colonization of the patient’s skin and prevent secondary environmental 
contamination (Milstone, Passaretti, & Perl, 2008). 
A CHG bathing protocol (Figure 1) utilizing impregnated cloths would direct nursing 
staff to perform whole body bathing; replacing traditional soap and water bathing during 
hospitalization.  Prepackaged cloths containing two to six large wipes for a full body wash 
provide an ideal medium for hospital bathing.  Cloths depending on manufacturing labels can be 
warmed or used at room temperature.  Each cloth is utilized for areas below the jaw line daily; 
episodes of incontinence are to be cleaned with non-medicated washcloths and water.  Bathing 
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with CHG cloths includes firm massage to remove bacteria.  Once bathed, a patient skin may feel 
sticky momentarily.  However, the skin should be allowed to air dry and not rinsed.  All lotions, 
ointments or emollients must be CHG compatible because some can inactivate the CHG. After 
cleansing each body area, device tubing within six inches of the patient should be cleansed 
including Foleys, drains, G-tube/J-tubes, rectal tubes, and chest tubes (Agency for Healthcare 
Research and Quality, 2013). 
Implementation of an Evidence-Based CLABSI Prevention Protocol  
Translating evidence into practice requires an integrated approach to address both 
mechanical and adaptive workflow, including a thorough understanding of the healthcare 
delivery system and human behavior (Pronovost, Berenholtz, & Needham, 2008).  Cultural 
change and the transformation in behaviors of healthcare workers significantly affect the 
reduction in HAIs, as seen in the 2006 Michigan Keystone Project (Pronovost et al., 2006).  The 
project implemented evidence-based preventive strategies recommended by the CDC along with 
focusing on changing provider behavior by creating a culture of safety, incorporating a 
centralized education program for team leaders at each institution, and closely collaborating with 
infection control personnel.  The intervention was extremely successful resulting in a large and 
sustained reduction (up to sixty-six percent) in rates of CLABSIs that was maintained throughout 
the eighteen-month study period (Pronovost et al., 2006). 
A recent document providing guidance for CLABSI prevention implementation identifies 
four key principles for strategy implementation: engaging, educating, executing, and evaluating 
(Marschall et al., 2014).  The engagement of hospital frontline staff and senior leadership is the 
first step in the process to implement a CLABSI protocol (Weaver et al., 2014).  Identifying and 
involving prevention champions can fuel organizational motivation by engaging and stimulating 
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peers.  Establishing a multidisciplinary team will encourage collaboration and create a culture of 
safety with promotion of accountability for prevention of CLABSI. Outcome data will be shared 
regularly with individual units.  Open communication with frontline staff will be maintained 
involving program improvement and sustainability (Marschall et al., 2014). Educational 
programs including CLABSIs prevention significance and appropriate bathing technique should 
be provided to all healthcare personnel involved in the direct delivery of CHG baths and vary in 
delivery method and evolving competencies.  
Program implementation will be executed by standardizing the care process to help 
increase staff compliance and prevention sustainability.  Quality improvement methodologies 
will be utilized to structure the prevention effort (Marschall et al., 2014).  Process measures will 
be evaluated by performing bathing audits and outcomes measures by trending CLABSI rates. 
Stakeholders and frontline staff will be provided with frequent program evaluation data.  Goals 
of improvement and outcomes should be clearly articulated and evaluated with mandatory 
competencies (Marschall et al., 2014).  Successful implementation requires the ongoing support, 
involvement, and shared accountability of hospital leadership, healthcare providers, payers, 
legislative leaders, and other members of the healthcare community who together are privileged 
with the responsibility for providing patients with safe, high-quality, high-value health care. 
Review of Evidence to Support Daily Chlorhexidine Gluconate Bathing 
A major mechanism of CLABSIs particularly with short-term devices, in place for ten 
days or fewer is the extra-luminal route, where skin microorganisms invade the percutaneous 
tract (Sadfar & Malki, 2004). One strategy is daily whole body patient bathing with 
chlorhexidine gluconate (CHG). Research indicates that daily bathing with two percent CHG-
impregnated cloths decreases patient bacterial skin colonization, healthcare workers hand 
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contamination, and environmental surface contamination (Vernon et al., 2006). Daily cleansing 
of ICU patients’ skin with CHG has been associated with reduced incidence of colonizations with 
vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA; 
Climo et al., 2009; Vernon et al., 2006), and multi-drug resistant Acinetobacter baumannii 
(Borer et al. 2007; Evans et al. 2010) and has been linked with decreased incidence of CLABSIs 
including those due to VRE and MDR A. baumannii (Bleasdale et al., 2007; Borer et al., 2007; 
Evans et al., 2010, Popovich et al., 2009).The Healthcare Infection Control Practices Advisory 
Committee (HICPAC) of the Centers for Disease Control and Prevention published revised 
CLABSI prevention guidelines in 2011 that included a category II recommendation for daily 
bathing with two percent CHG (O’Grady et al., 2011).  
The Cost-Benefit Analysis of Implementing the CHG Protocol 
Although no formal cost-benefit analysis is available in the literature, several studies 
evaluated CHG impregnated cloths and CLABSI preventions addressed the financial 
implications of using CHG impregnated cloths.  The cost of cloths is greater ($5.50 per bath) 
compared to the traditional soap and water ($1.46 per bath).  However, a projected cost savings 
of $1.56 million per year was estimated by reducing CLABSIs by 75 percent over a six month 
period when utilized in all ICUs (Holder & Zellinger, 2009).  Evans et al. (2010) estimated the 
cost of CHG impregnated cloths to be $5.52 per bath at the time of the trial as opposed to $1.23 
per bath for a bathing product that did not contain CHG. Dixon and Carver (2010) identified a 
$728,820 cost savings by using two percent CHG-impregnated cloths versus traditional soap and 
water over seventeen months of use.  After calculating the cost difference between switching to 
CHG impregnated cloth bathing, there was an equivalent to a savings of $945,000, which was 
more than ten times the cost of CHG bathing (Montecalvo et al., 2012).  A cost benefit analysis 
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for the implementation of a CHG bathing protocol includes staff training, product and CLABSI 
cost. Implementation in one hospital unit with 30 nurses and six nursing care assistants, each 
obtaining a one-hour in-service at $24/hr for nurses and $12/hr for assistants would total $822. 
Using the current market price of CHG impregnated cloths of $8.47 per bath and calculating for 
1000 central line days totals $8,470. Total protocol implementation cost would be $9,292. Using 
an estimated CLABSI cost of $39,000 if only one incidence of CLABSI is prevented the total 
savings is significant at $29,708 (Table 1; The Society of Healthcare Epidemiology of America, 
2014).  
Another important factor to address when assessing cost is nursing time to deliver CHG 
baths which hinges on the delivery method.  One study comparing bathing delivery methods 
found that the mean time to administer the traditional basin bath was 4.065 minutes, while the 
mean time of a CHG impregnated cloths bath was 3.314 minutes (Ritz et al., 2012).  This 
difference was statistically significant (t = 2.855; P = .008).  More time was likely saved when 
considering the time needed to gather bath supplies and linen for the traditional basin bath.  This 
time saved can be better utilized to optimize workflow thus having the potential for cost savings 
elsewhere.  
Conclusion 
Significant financial costs are associated with CLABSIs, in addition to the increased 
morbidity and mortality that results from these infections.  CLABSI costs include those related to 
diagnosis and treatment; prolonged hospital stays, and, more recently, lack of reimbursement by 
third-party payers for expenses incurred.  The economic consequences of CLABSIs and 
implemented prevention strategies can be complex to quantify, as many factors come into play.  
Identifying simple, cost-effective, and safe strategies for the prevention of HAIs is essential.  The 
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cost of providing any intervention merits consideration in a climate of cost containment.  Each 
institution negotiates prices with their vendors, so costs of the methods may vary. Daily bathing 
with two percent CHG impregnated cloths, as an adjunct therapy in the prevention of CLABSIs 
is promising for both improved patient outcomes and decreased healthcare costs.  
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Figure 1. Example Chlorhexidine Bathing Protocol  
 
 
Universal ICU Decolonization: An Enhanced Protocol (Agency for Healthcare Research and 
Quality, 2013) 
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Table 1. Cost Benefit Analysis  
 Cost Benefit Analysis in One Hospital Unit  
CLABSI cost per episode  $39,000** 
Chlorhexidine Gluconate 2% 
Impregnated cloths  
per bath $8.47* 
 
X 1000 central line days  
$8,470 
Educational In-service 
Nurses (30) - $25/hr classroom 
time 
$750 
Educational In-service  
Nursing Care Technicians (6) - 
$12.00/hr classroom time 
$72 
Potential Savings                                             $39,000 
$8,470  
   $750 
                                          -       $72 
                     $29,708  per hospital unit 
 
*price based on current market price per www.sage.com 
**The Society of Healthcare Epidemiology of America, 2014 
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Abstract 
 
Purpose: This practice inquiry project was designed to (i) evaluate adherence to a daily chlorhexidine 
gluconate (CHG) bathing guideline and (ii) to identify associations between guideline adherence and 
patient characteristics such as age, Injury Severity Score (ISS), Charlson Comorbidity Index score, 
location of central line, central line dwell time, and body mass index (BMI). 
Setting: This project took place in two 12-bed trauma/surgical intensive care units at the University of 
Kentucky Chandler Medical Center, an 875-bed American College of Surgeons accredited level 1 trauma 
center located in central Kentucky. 
Population: The sample consisted of 100 adult patients admitted with trauma-related diagnoses, Of the 
participants, 61 were male and 39 were female. The average age of the study participants was 48.65 years 
(SD = 18.7).  
Inclusion Criteria: Inclusion criteria were that participants were all adults (18 years or older) with the 
documented presence of a central line within 24 hours of admission to the intensive care unit, a diagnosis 
related to trauma, and no documented CHG allergy.  
Design and Methods: This retrospective descriptive study of  electronic medical records data used 
simple random sampling to retrieve 100 electronic medical records from the University of Kentucky 
Trauma Registrar Database from June 2013 to June 2014.  
Results: Patients received a CHG bath 60.5% of the days a central line was present. Further analysis 
showed 17% of patients received CHG baths each day a central line was present. Adherence did not vary 
significantly based on central line location.  Internal jugular lines were washed with CHG 61.3% of days, 
subclavian lines were washed with CHG 60.7% of days, and femoral lines were washed with CHG 50.7% 
of days. A statistically significant negative correlation was found between central line dwell days and 
guideline adherence with a Spearman’s rho = -0.48 and p < 0.0001. However, no evidence of correlation 
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between guideline adherence and the following existed: ISS (Spearman’s rho = -0.17; p < 0.091), BMI 
(Spearman’s rho = 0.15; p < 0.145), Charlson Comorbidity Score (Spearman’s rho = -0.05; p <0.603), or 
age (Spearman’s rho =0.13; p < 0.117). A Kruskal-Wallis Test revealed no statistically significant 
difference in guideline adherence across three different central venous catheter locations (χ² [2, n = 93] = 
0.293, p = 0.864). 
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An Evaluation of Chlorhexidine Gluconate Bathing in Trauma/Surgical Intensive Care Units: A 
Retrospective Chart Review 
Hospital-acquired infections (HAIs) are infections developed by patients while in the hospital 
receiving treatment for another condition (World Health Organization [WHO], 2011). HAIs may be 
caused by any infectious agent, including bacteria, fungi, and viruses, as well as other less common types 
of pathogens. The Healthcare Infection Control Practices Advisory Committee (HICPAC) of the Centers 
for Disease Control and Prevention (CDC) advises a variety of strategies to reduce HAIs. These strategies 
include hand hygiene, isolation practices, and meticulous sterile techniques for the placement of catheters 
(O’Grady et al., 2011). Central lines are intravascular catheters placed into a large vein in the neck 
(internal jugular vein), chest (subclavian vein or axillary vein), or groin (femoral vein). These catheters 
are common in the care of hospitalized, critically ill patients, as they provide reliable venous access for 
clinical activities such as blood sampling, infusion of medications, and hemodynamic measurement to 
inform fluid management decisions.  Although clinically useful, central lines are the leading cause of 
central line-associated bloodstream infections (CLABSIs) frequently implicated in life-threatening 
illnesses (U.S. Department of Health and Human Services, 2011; Klevens et al., 2007).  
CLABSIs are the sources of considerable morbidity and healthcare costs (CDC, 2011b; Burke, 
2003; Glance, Stone, Mukamel, & Dick, 2011). CLABSIs are one of the deadliest types of HAIs, with a 
mortality rate close to 18%. Forty-eight percent of intensive care unit (ICU) patients have central lines.  
This accounts for approximately 15 million central line catheter days per year (Institute for Healthcare 
Improvement, 2012). In addition, these bloodstream infections prolong hospitalization by a mean of seven 
days, thereby increasing the cost of care. The estimated attributable cost per infection is between U.S. 
$3,700 and $39,000 (Institute for Healthcare Improvement, 2012). The overall direct medical costs of 
HAIs (including CLABSIs) in hospitals in the United States range from  $28.4 to $33.8 billion annually 
(Klevens et al., 2007). 
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A major mechanism of CLABSIs, particularly with short-term devices in place for 10 days or 
less, is the extra-luminal route, where skin microorganisms invade the percutaneous tract (CDC, 2011; 
Safdar & Malki, 2004). One CLABSI prevention recommendation is bathing the patient’s skin with 
chlorhexidine gluconate (CHG), an antiseptic agent that has broad-spectrum activity against many 
organisms (Bleasdale et al., 2007; Popovich et al., 2009; Munoz-Price, et al. 2009; Marschall et al., 2014; 
Institute for Healthcare Improvement, 2012). Unlike many other antiseptics, CHG has residual 
antibacterial activity that may reduce the microbial colonization of patients’ skin and prevent secondary 
environmental contamination (Bleasdale et al., 2007; Climo et al., 2009).  
Research indicates that daily bathing with CHG decreases patient bacterial skin colonization, 
healthcare workers’ hand contamination, and environmental surface contamination (Vernon et al., 2006). 
Daily cleansing of ICU patients’ skin with CHG has been associated with the reduced incidence of 
colonization with vancomycin-resistant Enterococcus (VRE), methicillin-resistant Staphylococcus aureus 
(MRSA);(Climo et al., 2009; Vernon et al., 2006), and multidrug-resistant Acinetobacter baumannii 
(Borer et al. 2007; Evans et al. 2010). In possible correspondence, it has also been linked with a decreased 
incidence of CLABSIs, including those due to VRE and multidrug-resistant Acinetobacter baumannii 
(Bleasdale et al., 2007; Borer et al., 2007; Climo et al., 2009; Evans et al., 2010, Popovich et al., 2009).  
As the acuity of patients and the complexity of the healthcare system continue to intensify, patient and 
organizational outcomes are becoming more complex (U.S. Department of Health and Human Services, 
2011). As a result, it is important that hospitals, administrators, and providers address issues, like 
CLABSIs, and find solutions promptly. One vital step in quality assurance is to evaluate adherence to 
practice guidelines and policies developed to counteract a healthcare problem. According to the CDC, the 
recommended guidelines for the prevention of intravascular catheter-related infections identifies daily 
patient bathing with 2% CHG as an adjunct therapy in the prevention of CLABSIs (O’Grady et al., 2011; 
Marschall et al., 2014; Institute for Healthcare Improvement, 2012). The current policy at the University 
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of Kentucky Chandler Medical Center is that all patients over the age of one month, with a central line 
present, are to be bathed daily using a CHG solution (University of Kentucky Hospital, 2013).    
No current literature identifies associations between daily CHG bathing guideline adherence and 
patient characteristics.  However, literature does identify patient characteristics and factors that increase 
patients CLABSI risk, mortality, and impact nursing process, which when compounded may influence 
nursing adherence to daily CHG bathing for CLABSI prevention. One such characteristic that should be 
investigated is obesity. This is based on the grounds that the management of obese patients, particularly in 
the intensive care unit (ICU), is often physically strenuous and requires additional resources (Humphreys, 
2007; Twaij, et al., 2013). Challenges in caring for the obese population, includes turning, mobilizing, 
and adequately bathing. Safety during these tasks, for patient and staff, often requires more resources than 
many other populations.  These resources may not be consistently available, which may impact guideline 
adherence (Humphreys, 2007; Twaij, et al., 2013).  The hypothesis for this project was that the higher the 
patient’s BMI the less adherent nursing staff will be to daily CHG bathing. Patients that are larger in size 
may not receive daily CHG bathing because nursing staff may not have additional staff to complete the 
bathing and turning processes required.   
In clinical practice, age and co morbid conditions are taken into account when planning clinical 
management including pharmacotherapy, laboratory interpretation, and therapeutic regimens (Kircher, et 
al. 2007; Lea, et al., 2013). The Charlson Co-Morbidity Index was one of the first tools developed to 
measure the effects on mortality of co morbid conditions in hospitalized patients (Charlson et al., 1987). 
The Charlson Co-Morbidity has been widely used to measure co morbidities and has been extensively 
studied in a variety of populations including trauma (de Groot et al., 2003). As increased age and high co 
morbid burden are shown to have increased length of stay, ventilator days, and mortality risk following 
trauma these characteristics should be evaluated in trauma research, whether clinical, epidemiological, or 
quality improvement (Hollis, et al., 2006; Wutzler, et al., 2009;Valderas et al., 2009). The hypothesis for 
this project is that as age and Charlson Co-Morbidity Index increases so will guideline adherence.  The 
53 
 
 
 
nursing staff will view older patients and patients with a higher co morbid burden as more likely to have 
negative outcomes. Therefore they will be more diligent about adhering to guidelines that aim to prevent 
CLABSI and poor patient outcomes.  
Another important characteristic is quantifying the acuity of a patient such as using the Injury 
Severity Score in the trauma population. Among anatomical severity scores, the Injury Severity Score 
(ISS), created by Baker et al. in 1974 has been considered for over 20 years to be the gold standard to 
classify trauma victims, both blunt and penetrating. Just as injury severity guides clinical management, is 
an essential factor investigating guideline adherence it may also aid in practice improvement. An ISS 
score of 15 or higher is the nationally accepted criterion for triage of the trauma patient to a Level I 
center, as these patients have at least a 10% chance of dying from a single severe injury or multiple severe 
injuries (Baker et al., 1974). Due to these mortality implications in conjunction with CLABSI mortality, 
the hypothesis is made that as the ISS increases CHG bathing guideline adherence will also increase. In 
other words, the sicker the patient the more likely the nursing staff will be to adhere to CLABSI 
preventative guidelines and optimize patient outcome.  
There are two other important factors that should be considered in CLABSI prevention.  First is 
the length of time a central line is in place. Research has demonstrated that the longer a central line is in 
place the greater the likelihood of developing CLABSIs (Behrenholtz, et al., 2004; Pronovost, et al. 
2006). The hypothesis is the longer a patient has a central line the more adherent nursing staff will be to 
the CHG bathing guideline because of the known increased infection risk with longer dwelling central 
lines. The current Healthcare Infection Control Practices Advisory Committee recommends removing 
central venous lines as soon as safely possible to reduce infection and complication risk (Parenti et al., 
1994, Lederle et al., 1992; Pronovost, et al. 2006). The second is the anatomical location of the central 
line. The Infectious Disease Society of America (IDSA) and the Centers for Disease Control and 
Prevention (CDC) discourage the choice of femoral site for the insertion of central venous catheters due 
to increased risk for infection (Marschall et al, 2008; Merrer, et al., 2001; Goetz, et al., 1998; Robinson, et 
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al., 1995).  Therefore, the hypothesis is that nursing staff will be more compliant with the CHG daily 
bathing guideline in patients with a femoral line in order to reduce infection risk. 
Increased morbidity, mortality and negative patient outcomes combined with elevated healthcare 
cost, CLABSIs warrant considerable preventative efforts. Evaluating preventative efforts through 
guideline compliance is key practice improvement and decreasing CLABSI risk. By identifying, which 
patient characteristics or factors are associated with low guideline adherence then practice improvement 
can be focused, not only the overall importance of compliance but also draw attention to identified 
associations of low adherence.  
Description of Practice Inquiry Project 
This practice inquiry project evaluated adherence to the daily CHG bathing guideline in two 12-
bed trauma/surgical ICUs at the University of Kentucky Chandler Medical Center, an 875-bed level 1 
trauma center located in central Kentucky by conducting a retrospective medical chart review.  
Goals and Objectives 
The objectives of this project were to (i) evaluate provider adherence to a daily whole body CHG 
bathing guideline and (ii) to identify associations between guideline adherence and patient characteristics 
such as age, Injury Severity Score, Charlson Comorbidity Index score, BMI along with location of central 
line, central line dwell days. Based on these objectives, the primary goal of this project is to utilize results 
to inform decisions about need for quality improvement initiative aimed toward the prevention of 
CLABSIs.  
Methods 
Human Subject and Research Approval Procedures:  
Following the development of a project proposal and approval from the practice inquiry 
committee, approval was obtained from the University of Kentucky Nursing Research Council (Appendix 
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A). An expedited proposal was then submitted and subsequently approved by the hospital’s Institutional 
Review Board (IRB; Appendix B). Patient consent was waived in compliance with IRB regulations. 
Service line directors and ICU nurse managers were informed of the project via hospital email 
communication. Approval was obtained from the director of Trauma/Surgical Services (Appendix C). 
Study Setting:  
The study was conducted in two 12-bed trauma/surgical ICUs at the University of Kentucky 
Chandler Medical Center, an 875-bed, American College of Surgeons accredited level 1 trauma center 
located in central Kentucky.  
Study Design and Selection of Participants:  
A retrospective electronic medical chart review was performed. The study population inclusion 
criteria was all adult trauma patients, age 18 years and over with the documented presence of a central 
line within 24 hours of admission to one of the ICUs, no documented CHG allergy, and admission 
between June 2013 and June 2014. The Trauma/Surgical Service Department was utilized to access the 
UK HealthCare Trauma Database to obtain a generated report of patient medical record numbers with 
correlating Injury Severity Scores that met the sample population inclusion criteria. A total of 154 patients 
met the inclusion criteria. This generated report was in the form of an Excel spreadsheet. Using the 
random sample software within the Excel program, a simple random sample of 100 medical record 
numbers was selected. The master list consisted of the 100 medical records selected, and a study number 
was assigned to each individual medical record number. The study numbers were used on all data 
collection tool spreadsheets (Appendices D and E) and were kept separate from the master list.  
Utilizing this list, a total of 100 patient charts were reviewed and data were collected via 
electronic medical records. The data collected included the following: demographics (age, gender, and 
ethnicity), mechanism of injury, BMI, anatomical location of central line, and documentation of daily 
patient bathing during the presence of a central line. The anatomical location of central line and daily 
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bathing documentation includes documentation for each day the patient had a central line, if CHG 
solution was used for bathing, the Injury Severity Score, and co-morbid conditions in order to calculate 
the Charlson Comorbidity Index score.  
Measures:  
Guideline adherence for the purpose of this project is defined as documentation of a patient 
receiving a CHG bath once within every 24-hour period during the presence of a central line in the 
medical chart.  In the case of blank documentation a CHG bath was considered not done and adherence 
was considered noncompliant. The measures of association are between provider guideline adherence to 
patient characteristics including:  age, Injury Severity Score, Charlson Comorbidity Index score, location 
of central line, central line dwell days, and BMI. 
Instruments:  
The ISS reflects an anatomic scoring of injury severity and is generally recognized as a tool for 
retrospective application only. It is the injury severity score tool used by the University of Kentucky 
Trauma Database registrar and reported to regional and national trauma databases. It is calculated by 
assigning a severity score defined by the Abbreviated Injury Score (AIS) dictionary to any or all of the six 
body regions: head/neck, thorax, abdomen, extremities, external structure, and face. The scores range 
from 1 (minor) to 5 (critical—survival uncertain). A score of 6 may be assigned to a region that has an 
injury considered not survivable, as defined by the AIS dictionary. After all injuries are identified, scores 
are assigned by body region. The scores of the three most severely injured regions are squared and added 
together to calculate the ISS, which ranges from 1 to 75. An ISS score of 75 can be obtained any time a 
single body region is assigned an AIS of 6. An ISS score of 15 or higher is the nationally accepted 
criterion for triage of the trauma patient to a Level I center, as these patients have at least a 10% chance of 
dying from a single severe injury or multiple severe injuries (Baker et al., 1974). 
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The Charlson Comorbidity Index (Appendix D) predicts the 1-year mortality of a patient who 
may have a range of comorbid conditions. The index encompasses 19 medical conditions weighted 1–6, 
with total scores ranging from 0–37. Each condition is assigned a score of 1, 2, 3, 4, 5, or 6, depending on 
the risk of dying associated with each one. Scores are summed to provide a total score to predict 
mortality; the higher the score the higher the 10-year mortality rate (Charlson, Pompei, Ales, & 
MacKenzie, 1987). The Charlson Comorbidty Index was derived using a population of medical patients, 
and has been shown to be reliable and a valid predictor of mortality in a number of populations, including 
hospital inpatients and the critically ill (Charlson et al. 1987, Katz et al., 1996, Poses et al, 1996). 
Data Analysis:  
 Data analysis was performed using SPSS ® version 22.0 (SPSS Inc., Chicago, IL). Data were 
analyzed using descriptive and inferential statistics. Spearman rho correlation analysis was conducted to 
evaluate the association between guideline adherence and patient characteristics including age, Injury 
Severity Score, Charlson Comorbidity Index score, central line dwell days, and BMI. A Kruskal-Wallis 
Test was used to analyze association between guideline adherence and anatomical locations of central 
line. This study considered values of p < 0.05 to be statistically significant for the analysis.  
Results 
Sample Characteristics  
The demographics of the participants are presented in Table 1. Of the 100 study participants, 61 
were male and 39 were female. Their average age was 48.65 years (SD = 18.7), and they had a mean BMI 
of 28.6. A normal BMI is 18.5 to 24.9 with below 18.5 being underweight and above 24.9 overweight.  In 
terms of ethnicity, 93 were Caucasian, 4 were African American, 2 were Hispanic, and 1 was unknown. 
There was a total 589 central line days, with average dwell days of 5.9 and range from 1–19 days. The 
most frequent central line location was in the subclavian vein (Table 2). Over half of the patients’ 
diagnoses of trauma had a mechanism of action of motor vehicle accidents (MVA; 52%). This was 
58 
 
 
 
followed by falls (14%), motorcycle accidents (10%), gunshot wounds (8%), pedestrian versus car 
accidents (5%), all-terrain vehicle accidents (3%), farm-related accidents (3%), and unknown causes (5%) 
(Figure 1). The mean ISS for the sample population was 24.23 (Figure 2). A major trauma (or 
polytrauma) is defined as an ISS being greater than 15 (Copes et al., 1988). The mean Charlson 
Comorbidity Index score of the sample population was 1.07 (Figure 3).  
Guideline Adherence 
Analyses showed only 17% of patients received CHG baths each day a central line was present 
(Figure 4). Patients received a traditional soap and water bath 96.9% of days and a CHG bath only 60.5% 
of days (Figure 5). Guideline adherence per central line location was not significantly different. Internal 
jugular locations were washed with CHG 61.3% of days, subclavian locations were washed with CHG 
60.7% of days, and femoral locations were washed with CHG 50.7% of days (Figure 6).  
 Analysis  
 Spearman rho correlation analysis was conducted to assess if an association between guideline 
adherence and patient characteristics existed (Table 3). There was a statistically significant negative 
correlation between length of central line days and guideline adherence, with a Spearman rho = -0.48 and 
p < 0.0001. However, there was no evidence of correlation between guideline adherence and the 
following: ISS (Spearman rho = -0.17; p < 0.091), BMI (Spearman rho = 0.15; p < 0.145), Charlson 
Comorbidity Score (Spearman rho = -0.05; p <0.603), or age (Spearman rho =0.13; p <0.117). A Kruskal-
Wallis Test revealed no statistically significant difference in guideline adherence across three different 
central venous catheter locations (χ² [2, n = 93] = 0.293, p = 0.864);( Table 4). 
Discussion 
Central line-associated bloodstream infections result in thousands of deaths each year and billions 
of dollars in added healthcare costs. Fortunately, these infections are preventable and evidence based 
practice guidelines and institutional policies are the foundation of prevention.  
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Important risk factors associated with CLABSIs include poor staff adherence to infection prevention 
practices during insertion and care for these devices when in place. These infections are considered an 
avoidable risk to patient safety, and recommendations have been issued from professional and national 
agencies to focus on their prevention (Burke, et al., 2003; Pittet, et al., 2006; Yokoe, et al., 2008). 
However, there is concern that healthcare professionals may be inconsistent with adherence to guidelines 
or quality improvement interventions. Inherently, this may place the vulnerable patient at risk for device 
related infections. 
The implementation and use of clinical practice guidelines among nurses is a complex process in 
which social and organizational barriers concerning workload, communication, and education play an 
important role (Abrahamson, Fox, & Doebbeling, 2012).This project was designed to evaluate adherence 
to a CLABSI preventative guideline and to identify practice gaps in daily CHG bathing care delivery by 
examining guideline adherence with patient characteristics. The results demonstrated extremely poor 
guideline adherences at only 17%. Meaning that out of 100 patients only 17 received a daily CHG bath 
during the entire length of central line dwell time. These findings are damaging to CLABSI prevention 
efforts because they demonstrate a lack in prevention thus increasing the risk for CLABSIs development. 
Of the 589 central line days analyzed, patients’ received a CHG bath 60.5% of the days. However, 
patients’ received a traditional soap and water bath 96.9% of the days). As discussed data extraction was 
from nursing documentation and must be factored in to any analysis of guideline adherence. Due to the 
significant difference in CHG baths document versus soap and water baths it leads to question the 
logistics of nursing documentation. Including where within the electronic chartings is CHG bathing 
documented. The low rate of compliance may be secondary to the additional steps required for complete 
documentation. 
 A statistically significant, negative correlation between guideline adherence and central line 
dwell days was identified. As central line dwell days increased, CHG bathing adherence decreased. 
Currently no other research is available to compare if these findings are a pattern. However, research has 
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shown that the longer a central line is in place the greater the likelihood of developing CLABSIs 
(Behrenholtz, et al., 2004; Pronovost, et al. 2006).  Analysis found no other statistically significant 
associations between guideline adherence and age, BMI, central line location, ISS, or Charlson 
Comorbidity index. These findings are interesting due to the fact that line placement location and length 
of dwell time has long been associated with increased risk of infection (Behrenholtz, et al., 2004; 
Pronovost, et al. 2006). A lack of association between guideline adherence and central line location is 
interesting due to the continued emphasis on femoral line placement being at higher risk for infection 
(O’Grady et al., 2011). These findings warrant further investigation into nursing staff knowledge around 
CLABSI risk factors.  
The lack of association between guideline adherence and Charlson Comorbidity Index may be 
attributed to the sample population’s particularly low mean score of 1.07. This indicates that the patients 
making up the sample population had very few preexisting conditions and/or comorbidities. The Charlson 
Comorbidity Index itself was not developed specifically for trauma patients, which may explain the lack 
of significant findings in the current study. However, the median age of the sample population patients 
being quite young at 48.65 years, which correlates with trauma being the leading cause of death for 
people ages 1-44 in the United States may be another factor of the low Charlson Comorbidity Index 
(Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2011). 
However, 80% of older adults have one chronic condition, and 50% have at least two. Infectious diseases 
and injuries also take a disproportionate toll on older adults (Bell, 2014; Fuchs, et al., 2012). Efforts to 
identify strategies to prevent or reduce the risk of disease and injury and to widely apply effective 
interventions must be promptly implemented.  
An absence of association between guideline adherence and ISS was surprising due to a relatively 
high mean ISS. The mean ISS for the sample population was 24.23 and an ISS of 15 or greater qualifies 
for triage at a Level I center, as these patients have at minimum a 10% chance of dying from injuries 
(Baker et al., 1974). Considering that patients with higher ISS scores have a higher chance of mortality, it 
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may be hypothesized that the higher chance of mortality may motivate adherence. The findings of this 
project identified a clear need for further quality improvement work in CHG bathing guideline adherence; 
such as poor guideline adherence and the finding of a negative correlation between central line dwell days 
and guideline adherence. Nurses are central in hospital efforts to improve quality care and their 
involvement in future improvement will be vital to its success.  
Limitations 
The limitations of this project include the small sample size and the retrospective chart review 
design, both of which may affect the validity of the study results. The small sample size minimized the 
statistical power and thus under powers the strength of the conclusions. Clinical significance could be 
looking into documentation practices to make it more likely documentation of CHG baths will be accurate 
therefore making the statistics more accurate and reliable. The retrospective design of the study using a 
chart review method represents self-reported documentation of tasks completed and thus must be 
considered when reviewing results. No real-time observation was conducted; therefore, the data extracted 
must be factored into the validity of the study results. The study population included only patients’ in the 
Trauma/Surgical Service Line; thus, conclusions cannot be generalized to other areas within the 
institution or to other patient populations. Another limitations is that nursing staff patterns were not 
examined during this project which have been shown to impact nursing practice and patient outcomes 
(Mefford & Alligood, 2011; Kane et al., 2007). 
Implications for Practice 
 The prevention of HAIs, including CLABSIs, requires a multi-disciplinary approach.  
However, bedside nurses are in a key position to lead preventative practices and improve  
patient outcomes. The current policy at the University of Kentucky Chandler Medical Center is that all 
patients over the age of one month with a central line present are to be bathed daily using a CHG solution 
(University of Kentucky Hospital, 2013). The results of this study suggest that a substantial quality 
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improvement initiative is warranted to improve CHG bathing policy adherence. Armed with this evidence 
nurse managers and service line directors should address nursing staff with the low policy adherence.  
Should first implement intense educational program aimed at risk factors for CLABSI and nursing 
interventions that can impact those outcomes. 
Communication between bedside nursing staff and administration should include both facilitators 
and barriers of policy adherence. While gaining input, education is also important. Individuals that 
understand the purpose and evidence behind change are more likely to adapt and implement a change. 
Instituting an educational module on the guideline itself and emphasizing the importance of 
documentation is critical. Additionally, routine competencies will be necessary to improve and sustain 
guideline adherence. The Trauma/Surgical Service Department has an opportunity to reach out for 
support from hospital administration and senior leadership to develop and implement a program targeted 
at increasing nursing knowledge and awareness of the guideline policy throughout the enterprise.  
Implications for Future Research 
Future research should include a more rigorous study design to evaluate guideline adherence and 
perceived facilitators and barriers to adherence and include staffing patterns. This project looked at 
overall guideline adherence rather than the delivery method of the CHG bath. The current delivery 
method of CHG bathing at the University of Kentucky Medical Center involves traditional water basins, 
non-medicated cloths and a 4% liquid CHG solution. Investigation of care providers’ CHG bathing 
delivery is also warranted to assure proper delivery technique is applied. As CLABSIs and other 
healthcare-associated bloodstream infections are becoming increasingly common outside the ICU, CHG 
daily bathing guideline adherence should also be examined in non-ICU settings with different patient 
populations. 
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Conclusion  
The development of a CLABSI carries significant health risk and financial burden and requires 
the attention of every clinician involved in the management of affected patients. The commitment to 
preventing central line associated bloodstream infections gained national momentum with the 100,000 
Lives Campaign in 2005 (Berwick, Calkins, McCannon, & Hackbarth, 2006). As pay-for-performance 
takes full effect, hospital-acquired infection prevention protocols have been gaining popularity and are 
critical to both patient outcomes and the sustainability of organizations. The Centers for Medicare and 
Medicaid Services (CMS) has not reimbursed hospitals for the costs of care associated with certain HAIs, 
including surgical site infections, CLABSIs, and catheter-associated urinary tract infections, since 2008. 
Many organizations have developed and implemented various evidence-based practice (EBP) guidelines 
that have not only improved patient outcomes but have saved millions of healthcare dollars. The results of 
this study provide evidence that further research is necessary to build on this educational intervention in 
order to design, implement, and evaluate programs that are effective and sustainable over time. 
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Figure 1: Sample mechanism of action demographics  
Note. MVA= Motor Vehicle Accident, MCA =Motorcycle Accident, GSW=Gun Shot Wound, 
Ped=Pedestrian, ATV= All-terrain Vehicle  
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Figure 2: Distribution of Injury Severity Scores  
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Figure 3: Distribution of Charlson Comorbidity Scores  
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Figure 4: Guideline adherence 
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Figure 5: Percentage of days receiving bath (by type) 
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Figure 6: Guideline adherence by central line location 
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Table. 3 Spearman Rho Analysis  
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Table. 4 Kruskal-Wallis Test 
 
Ranks 
 
Type of line N 
Mean 
Rank 
Percent of total 
days had chg 
bath 
SC ony 45 46.72 
IJ only 39 46.27 
Fem only 9 51.56 
Total 93  
 
Test Statisticsa,b 
 
Percent of 
total days 
had chg bath 
Chi-Square .293 
df 2 
Asymp. 
Sig. 
.864 
a. Kruskal Wallis Test 
b. Grouping Variable: Type 
of line 
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Conclusion  
The original “Making Health Care Safer” report examined the prevalence, strategies, and 
costs associated with CLABSI prevention, and found that certain practices were associated with 
both a decrease in CLABSI risk and reduced cost, whereas others added expense without clear 
benefit (Shojania et al., 2001). The efforts made for CLABSI prevention exemplify not only the 
complexity of these infections but also the creativity required to stop them. This practice inquiry 
practice identifies a simple adjunct strategy for the prevention of CLABSIs. Manuscript one 
reviews the literature on daily CHG whole body patient bathing and identifies it to be an effective 
adjunct CLABSI prevention technique. National regulatory agencies and professional 
organizations support the use of daily CHG bathing during the presence of a central line and is 
recommended adjunct therapy as part of a routine CLABSI prevention protocol (O’Grady et al., 
2011; The Society of Healthcare Epidemiology of America, 2014). Daily bathing with CHG 
impregnated washcloths is a strategy that is relatively straightforward to implement because it 
does not require a substantial change from patient-bathing practices that are currently routine. 
Manuscript 2 highlighted a daily CHG bathing protocol using CHG impregnated cloths and 
demonstrated its potential cost savings through a cost benefit analysis. Manuscript 3 evaluated 
current CHG bathing guideline adherence in two trauma/surgical ICUs and associations between 
patient characteristics and factors that may impact adherence. The findings of this project 
showed significantly low guideline adherence. Further work is warranted to increase CHG daily 
bathing guideline compliance for CLABSI prevention.  
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Appendix D: Charlson Comorbidity Index 
 
 
 
 
Charlson Comorbidity Index 
Pt. ID # _____________________ 
Does the Patient have?  
1.Myocardial infarction  No Yes Score 1 
2.Congestive Heart Failure No Yes Score 1 
3.Peripheral Vascular disease  No Yes   Score 1 
4.Cerebrovascular Disease  No Yes Score 1  
5.Dementia  No Yes Score 1 
6.Chronic Pulmonary disease  No Yes Score 1 
7.Connective tissue disease  No Yes Score 1 
8.Stomach or Peptic ulcer disease  No Yes Score 1 
9.Hemiplegia  No Yes Score 2 
10.Diabetes  No Yes Score 1 
11.If yes, has the diabetes caused any organ damage  No Yes Score 2 
12.Moderate to severe renal disease  No Yes Score 2  
 13.Mild Liver disease No Yes Score 1 
 14.Cirrhosis or serious liver disease No Yes Score 3 
 15.AIDS No Yes Score 6 
 16.Leukemia  No Yes Score 2 
17.Lymphoma No Yes Score 2 
18. Cancer other than skin cancer, leukemia, or lymphoma with 
the last 5 years?  
No Yes Score 2 
19. If yes, has the cancer spread or metastasized to other parts 
of the body?  
No Yes  Score 6  
                                                                                                                                                          Total Score = 
90 
 
 
 
Appendix E: Data Collection Tool 
 
Data Collection Tool   Patient Study Number # __________________ Sex: Male or Female Age: _______ Race: Caucasian, African American, Hispanic, Other Mechanism of Injury:__________________________ Injury Severity Score: _______ Charlson Comorbidity Index: __________ Body Mass Index (BMI): ______ 
Key: CHG= Chlorhexidine Gluconate, IJ= Intrajugular, SC=Subclavian 
Day of central line  Location of Central line IJ =1 SC=2 Femoral=3 
Daily bath  Received Yes=1 No=2 Blank=3 
CHG Used for Bathing Yes=1 No=2 Blank=3 
1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    
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